Skip to main content
Amoéba logo

Amoéba — Investor Relations & Filings

Ticker · ALMIB ISIN · FR0011051598 LEI · 9695005QNE7C8Z0LXU64 PA Manufacturing
Open in API
Filings indexed 563 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country FR France
Listing PA ALMIB

About Amoéba

https://amoeba-nature.com/en/

Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.

Recent filings

Filing Released Lang Actions
Amoéba obtient en Italie une autorisation d'urgence de 120 jours pour son biofongicide contre le mildiou du basilic
Regulatory Filings Classification · 85% confidence The document is a corporate press release in French announcing the granting of an emergency use authorization for a biofungicide product in Italy. It contains no financial statements, no management or board changes, no share transactions, no call transcript or earnings data, and no notice of report publication. It is an operational/regulatory update rather than a formal financial or governance filing. Therefore it falls under the fallback category of general regulatory announcements (RNS).
2026-06-08 French
Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew
Regulatory Filings Classification · 62% confidence The document is a corporate press release announcing a regulatory approval (a 120-day emergency authorization from the Italian Ministry of Health) for the company’s biofungicide. It contains no financial results, no management discussion of financial performance, and is not a proxy or capital markets filing. It is an operational/regulatory announcement, which falls under the catch-all category of Regulatory Filings (RNS).
2026-06-08 English
Deux nouvelles dérogations exceptionnelles d'utilisation aux Pays-Bas en 2026 pour la solution de biocontrôle d'Amoéba
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Amoeba has obtained two exceptional authorizations for the use of its biocontrol solution in the Netherlands in 2026. It details the permits granted by the Dutch regulatory authority CTGB, the strategic importance of the Dutch market, and the ongoing regulatory process towards permanent authorization. The document does not contain financial statements, detailed financial performance data, or regulatory filings such as annual or interim reports. It is a corporate announcement about regulatory approvals and market development rather than a financial or governance report. It is not a report publication announcement since it does not mention the release or availability of a report. It is also not a regulatory filing or certification. The content fits best under a general regulatory announcement or corporate update category. Given the available categories, the closest fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory or corporate announcements that do not fit other specific categories.
2026-05-06 French
Two new exceptional trial permits in the Netherlands in 2026 for Amoéba's biocontrol solution
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Amoeba and Koppert have received two exceptional trial permits in the Netherlands for their biocontrol solution AXPERA. It discusses regulatory approvals, trial permits, and market strategy but does not contain any financial statements, earnings data, or detailed financial analysis. There is no indication that this is a financial report, earnings release, or regulatory filing of financial results. The document is informational about regulatory and trial permit updates, which fits best under a general regulatory announcement category. It is not a report publication announcement since it does not mention the release or availability of a report, nor is it a certification or attestation. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-06 English
Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards
Regulatory Filings Classification · 72% confidence The document is a corporate press release announcing an emergency marketing authorization from a French regulatory authority for the company’s biocontrol product. It is not a financial report (10-K, IR, ER), governance document (AGM, PSI, CGR), share transaction, dividend, or capital raising notice. It does not present financial results or detailed ESG data, nor is it announcing the publication of another report. This is a general regulatory announcement that does not fit any other specific category, making Regulatory Filings (RNS) the appropriate classification.
2026-04-28 English
Amoéba obtient une nouvelle autorisation d'urgence pour l'utilisation de la solution de biocontrôle AXPERA afin de protéger les vignobles français
Regulatory Filings Classification · 90% confidence The document is a corporate press release announcing that Amoeba obtained a new emergency phytosanitary marketing authorization for its biocontrol product AXPERA. It does not present financial results, management changes, share transactions, or dividend information. It is a regulatory announcement regarding product approval and thus falls under the fallback category for miscellaneous regulatory filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-28 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.